JP2009001575A5 - - Google Patents

Download PDF

Info

Publication number
JP2009001575A5
JP2009001575A5 JP2008163588A JP2008163588A JP2009001575A5 JP 2009001575 A5 JP2009001575 A5 JP 2009001575A5 JP 2008163588 A JP2008163588 A JP 2008163588A JP 2008163588 A JP2008163588 A JP 2008163588A JP 2009001575 A5 JP2009001575 A5 JP 2009001575A5
Authority
JP
Japan
Prior art keywords
ozone
ppm
mucous membrane
external preparation
initial concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008163588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009001575A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008163588A priority Critical patent/JP2009001575A/ja
Priority claimed from JP2008163588A external-priority patent/JP2009001575A/ja
Publication of JP2009001575A publication Critical patent/JP2009001575A/ja
Publication of JP2009001575A5 publication Critical patent/JP2009001575A5/ja
Pending legal-status Critical Current

Links

JP2008163588A 2008-06-23 2008-06-23 オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤 Pending JP2009001575A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008163588A JP2009001575A (ja) 2008-06-23 2008-06-23 オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008163588A JP2009001575A (ja) 2008-06-23 2008-06-23 オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006166364A Division JP2007332078A (ja) 2006-06-15 2006-06-15 オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤

Publications (2)

Publication Number Publication Date
JP2009001575A JP2009001575A (ja) 2009-01-08
JP2009001575A5 true JP2009001575A5 (enExample) 2009-07-30

Family

ID=40318354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008163588A Pending JP2009001575A (ja) 2008-06-23 2008-06-23 オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤

Country Status (1)

Country Link
JP (1) JP2009001575A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101244112B1 (ko) * 2011-07-21 2013-03-18 주식회사 탑 엔지니어링 태양전지용 광흡수층 제조방법, 이를 포함하는 태양전지 및 이의 제조방법
KR101514343B1 (ko) * 2013-12-23 2015-04-22 참좋은우리 주식회사 라벤터 에센셜 오일을 첨가한 오존화 올리브 오일 제조방법
CN104644467B (zh) * 2015-02-12 2016-01-20 安婕妤化妆品科技股份有限公司 一种含富勒烯衍生物的化妆品
ITUB20156870A1 (it) * 2015-12-11 2017-06-11 Laboratori Baldacci Spa Combinazione sinergica di acido pirrolidoncarbossilico e/o suoi sali o derivati e acido ialuronico e/o suoi sali, per uso nel trattamento e/o prevenzione della secchezza e dell'irritazione delle mucose, e relative formulazioni farmaceutiche.
JP7575652B2 (ja) * 2023-02-20 2024-10-30 株式会社メディプラス製薬 オゾン処理グリセリン、オゾン処理グリセリンの製造方法、化粧料、飲食品、及び口腔用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2271395T3 (es) * 2002-02-23 2007-04-16 Hwajin Cosmetics Co., Ltd. Sistema de tratamiento total de la piel y procedimiento que utiliza el mismo.
JP4677192B2 (ja) * 2004-02-20 2011-04-27 株式会社オゾテック オゾン溶存グリセリン溶液の製造方法

Similar Documents

Publication Publication Date Title
LTC2340031I2 (lt) Gdf gaudyklės, skirtos naudoti anemijos gydymui
JP2011506530A5 (enExample)
HUE053946T2 (hu) 4'-Fluor-nukleozidok, 4'-fluor-nukleotidok és analógjaik HCV kezelésére
EP2424975A4 (en) Organisms for the production of 1,3-butanediol
UY31765A (es) Dihidropirazolonas sustituidas y su uso
BRPI0917006A2 (pt) agente de liberação prolongada de droga, adsorvente, alimento, máscara tendo um adsorvente, e, folha de adsorção
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
IL211328A0 (en) Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
DOP2007000102A (es) Arilimidazolonas y ariltriazolona sustituidas asi como su uso
HRP20181727T1 (hr) Upotreba protutijela protiv čimbenika xi, namijenjena sprečavanju ili liječenju stvaranja krvnog ugruška
WO2010036395A3 (en) Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
BR112013004846A2 (pt) ''menbrana antimicrobiana,filtro,dispositivo de purificação de água e processo para fazer uma menbrana antimicrobiana''.
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
ITMI20091618A1 (it) Pezzo composito, nonche' impiego del pezzo composito
JP2012501683A5 (enExample)
HK1203388A1 (en) Polymer-based dialysate
EP2300599A4 (en) INCREASING THE EFFECTIVENESS OF CELL THERAPY, INCLUDING TREATMENT WITH ALPHA-1-3-FUCOSYLTRANSFERASE
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
CL2007003190A1 (es) Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras.
JP2011510778A5 (enExample)
HRP20171742T1 (hr) 2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
JP2009001575A5 (enExample)